An elevated plasma level of homocysteine is a risk factor for the development of cardiovascular disease. The purpose of this study was to investigate the effect of glucagon on homocysteine metabolism in the rat. Male Sprague-Dawley rats were treated with 4 mg/kg/day (3 injections per day) glucagon for 2 days while control rats received vehicle injections. Glucagon treatment resulted in a 30% decrease in total plasma homocysteine and increased hepatic activities of glycine N-methyltransferase, cystathionine -synthase, and cystathionine ␥-lyase. Enzyme activities of the remethylation pathway were unaffected. The 90% elevation in activity of cystathionine -synthase was accompanied by a 2-fold increase in its mRNA level. Hepatocytes prepared from glucagon-injected rats exported less homocysteine, when incubated with methionine, than did hepatocytes of saline-treated rats. Flux through cystathionine -synthase was increased 5-fold in hepatocytes isolated from glucagon-treated rats as determined by production of 14 CO 2 and ␣-[1-14 C]ketobutyrate from L-[1-14 C]methionine. Methionine transport was elevated 2-fold in hepatocytes isolated from glucagon-treated rats resulting in increased hepatic methionine levels. Hepatic concentrations of S-adenosylmethionine and S-adenosylhomocysteine, allosteric activators of cystathionine -synthase, were also increased following glucagon treatment. These results indicate that glucagon can regulate plasma homocysteine through its effects on the hepatic transsulfuration pathway.An elevated plasma concentration of homocysteine, a sulfurcontaining amino acid derived from methionine, has been recognized as an independent risk factor for the development of vascular disease (1). Methionine is adenylated by methionine adenosyltransferase to form S-adenosylmethionine, an important biological methyl donor. Numerous methyltransferases catalyze the transfer of a methyl group from S-adenosylmethionine to a methyl acceptor, producing a methylated product and S-adenosylhomocysteine, which is subsequently hydrolyzed to form adenosine and homocysteine. Homocysteine has several possible fates: 1) remethylation to form methionine via either the cobalamin-dependent methionine synthase (using N 5 -methyltetrahydrofolate as a methyl donor) or betaine:homocysteine methyltransferase (using betaine as a methyl donor); 2) catabolism by the transsulfuration pathway, ultimately forming cysteine; 3) export to the extracellular space. Two vitamin B 6 -dependent enzymes comprise the transsulfuration pathway: cystathionine -synthase, which condenses homocysteine with serine to form cystathionine, and cystathionine ␥-lyase, which cleaves cystathionine to cysteine, NH 4 ϩ , and ␣-ketobutyrate.Altered flux through the remethylation or transsulfuration pathways as a result of genetic mutations or impaired vitamin status has been shown to affect plasma homocysteine levels (2, 3). In recent years it has also become apparent that certain hormones can affect homocysteine metabolism. It has been shown that hypothyroid ...